Amryt Pharma invested in Aegerion Pharmaceuticals, Inc on May 20, 2019.
8-KAP Services and Moelis & Companyfirm advised the seller.
8-KDucera Securitiesfirm and Evercore Groupfirm advised on the deal.
8-KThe filing puts the value at $395M.
8-KMoelis & Companyfirm also worked on MidCap Financial Investment Corporationdeal, on Oct 27, 2026.
8-K
At a glance
Who was on each side
Seller's adviserAP Services
Seller's adviserMoelis & Company
The companyAegerion Pharmaceuticals, Inc$395Menterprise valueMay 20, 2019
BuyerAmryt Pharma
Also on the deal: Ducera Securities (adviser), Evercore Group (adviser)
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Price | $395M | enterprise value | 8-K |
More deals
first 2 of 11
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 29, 2026 | ADT Inc · Sale | Thrive Capital, Citigroup Global Markets | 8-K |
| Oct 27, 2026 | MidCap Financial Investment Corporation · Merger | Ares Management, Ares Management | 8-K |
9 more deals
Deals with Moelis & Company, Ducera Securities and Evercore Group.
Sign up free to see the first 5, or become a member to see all 11.